BRPI1008501A2 - derivados de 3-benzo furanil - indol-2-ona substituídos em posição 3, o respectivo preparo e a respectiva aplicação em terapêutica - Google Patents

derivados de 3-benzo furanil - indol-2-ona substituídos em posição 3, o respectivo preparo e a respectiva aplicação em terapêutica

Info

Publication number: BRPI1008501A2
Authority: BR; Brazil
Prior art keywords: indol; derivatives; substituted; preparation; therapeutic application
Prior art date: 2009-02-12

Application number

BRPI1008501A

Other languages

English (en)

Inventor

Puleo Letizia

Baroni Marco

Original Assignee

Sanofi Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-02-12

Filing date

2010-02-09

Publication date

2019-09-24

2010-02-09 Application filed by Sanofi Sa filed Critical Sanofi Sa

2019-09-24 Publication of BRPI1008501A2 publication Critical patent/BRPI1008501A2/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Diabetes (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Hematology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Obesity (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Child & Adolescent Psychology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

BRPI1008501A 2009-02-12 2010-02-09 derivados de 3-benzo furanil - indol-2-ona substituídos em posição 3, o respectivo preparo e a respectiva aplicação em terapêutica BRPI1008501A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0900622A FR2941947B1 (fr)	2009-02-12	2009-02-12	Derives de 3-benzofuranyl-indol-2-one subtitues en 3, leur preparation et leur application en therapeutique
PCT/FR2010/050207 WO2010092289A1 (fr)	2009-02-12	2010-02-09	Derives de 3-benzofuranyl-indol-2-one substitues en position 3, leur preparation et leur application en therapeutique

Publications (1)

Publication Number	Publication Date
BRPI1008501A2 true BRPI1008501A2 (pt)	2019-09-24

Family

ID=40756659

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI1008501A BRPI1008501A2 (pt)	2009-02-12	2010-02-09	derivados de 3-benzo furanil - indol-2-ona substituídos em posição 3, o respectivo preparo e a respectiva aplicação em terapêutica

Country Status (17)

Country	Link
US (1)	US20120040996A1 (pt)
EP (1)	EP2396320B1 (pt)
JP (1)	JP5694959B2 (pt)
KR (1)	KR20110115161A (pt)
CN (1)	CN102361865B (pt)
AR (1)	AR075399A1 (pt)
AU (1)	AU2010212705B2 (pt)
BR (1)	BRPI1008501A2 (pt)
CA (1)	CA2752199A1 (pt)
FR (1)	FR2941947B1 (pt)
IL (1)	IL214543A0 (pt)
MX (1)	MX2011008578A (pt)
RU (1)	RU2542991C2 (pt)
SG (1)	SG173622A1 (pt)
TW (1)	TWI457335B (pt)
UY (1)	UY32447A (pt)
WO (1)	WO2010092289A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2941946B1 (fr) *	2009-02-12	2011-03-25	Sanofi Aventis	Derives de 3-benzofuranyl-indol-2-one-3-acetamidopiperazines substitues, leur preparation et leur application en therapeutique
CA2778990A1 (en)	2009-10-30	2011-05-05	Tranzyme Pharma, Inc.	Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same
CN115745958A (zh) *	2022-10-28	2023-03-07	中新科农(山东)生态农业有限公司	一种吲哚-2-酮类化合物及其作为杀菌剂的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4127849A1 (de) *	1991-08-22	1993-02-25	Merck Patent Gmbh	Benzodioxanderivate
FR2714378B1 (fr)	1993-12-24	1996-03-15	Sanofi Sa	Dérivés de l'indol-2-one substitués en 3 par un groupe azoté, leur préparation, les compositions pharmaceutiques en contenant.
CN1161333C (zh) *	1998-08-20	2004-08-11	住友制药株式会社	作为生长激素释放剂的2-羟基吲哚衍生物
DE19934432A1 (de) *	1999-07-22	2001-02-01	Merck Patent Gmbh	Indolderivate
JP2004501192A (ja) *	2000-06-29	2004-01-15	ニューロサーチ、アクティーゼルスカブ	Ｋｃｎｑカリウムチャネルモジュレーターとしての３−置換オキシインドール誘導体の使用方法
US6939887B2 (en) *	2001-01-30	2005-09-06	Sumitomo Pharmaceuticals Co., Ltd.	Benzimidazolidinone derivatives
FR2827604B1 (fr) *	2001-07-17	2003-09-19	Sanofi Synthelabo	Nouveaux derives de 1-phenylsulfonyl-1,3-dihydro-2h-indol-2- one, un procede pour leur preparation et les compositions pharmaceutiques en contenant
NZ541064A (en) *	2003-03-07	2007-09-28	Kowa Co	Benzofuran derivative
US20050070718A1 (en) *	2003-09-30	2005-03-31	Abbott Gmbh & Co. Kg	Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them
WO2005035498A1 (ja) *	2003-10-08	2005-04-21	Dainippon Sumitomo Pharma Co., Ltd.	含窒素二環性化合物の摂食調節剤としての用途
EP1935883A4 (en) *	2005-09-14	2010-07-21	Dainippon Sumitomo Pharma Co	OXINDOL DERIVATIVES AS A MEANS FOR CONTROLLING FOOD RECEPTION
FR2920023B1 (fr) *	2007-08-16	2013-02-08	Sanofi Aventis	Derives de l'indol-2-one disubstitues en 3, leur preparation et leur application en therapeutique
FR2941946B1 (fr) *	2009-02-12	2011-03-25	Sanofi Aventis	Derives de 3-benzofuranyl-indol-2-one-3-acetamidopiperazines substitues, leur preparation et leur application en therapeutique

2009
- 2009-02-12 FR FR0900622A patent/FR2941947B1/fr not_active Expired - Fee Related
2010
- 2010-02-09 WO PCT/FR2010/050207 patent/WO2010092289A1/fr active Application Filing
- 2010-02-09 US US13/201,138 patent/US20120040996A1/en not_active Abandoned
- 2010-02-09 MX MX2011008578A patent/MX2011008578A/es active IP Right Grant
- 2010-02-09 CN CN201080012995.3A patent/CN102361865B/zh not_active Expired - Fee Related
- 2010-02-09 EP EP10708307.3A patent/EP2396320B1/fr active Active
- 2010-02-09 KR KR1020117020972A patent/KR20110115161A/ko not_active Withdrawn
- 2010-02-09 AU AU2010212705A patent/AU2010212705B2/en not_active Ceased
- 2010-02-09 CA CA2752199A patent/CA2752199A1/fr not_active Abandoned
- 2010-02-09 SG SG2011057544A patent/SG173622A1/en unknown
- 2010-02-09 JP JP2011549643A patent/JP5694959B2/ja not_active Expired - Fee Related
- 2010-02-09 BR BRPI1008501A patent/BRPI1008501A2/pt not_active IP Right Cessation
- 2010-02-09 RU RU2011137435/04A patent/RU2542991C2/ru not_active IP Right Cessation
- 2010-02-11 AR ARP100100379A patent/AR075399A1/es unknown
- 2010-02-11 TW TW099104421A patent/TWI457335B/zh not_active IP Right Cessation
- 2010-02-12 UY UY0001032447A patent/UY32447A/es not_active Application Discontinuation
2011
- 2011-08-09 IL IL214543A patent/IL214543A0/en unknown

Also Published As

Publication number	Publication date
JP2012517461A (ja)	2012-08-02
SG173622A1 (en)	2011-09-29
AU2010212705B2 (en)	2016-03-17
CA2752199A1 (fr)	2010-08-19
EP2396320A1 (fr)	2011-12-21
KR20110115161A (ko)	2011-10-20
UY32447A (es)	2010-09-30
JP5694959B2 (ja)	2015-04-01
RU2542991C2 (ru)	2015-02-27
FR2941947B1 (fr)	2011-03-25
MX2011008578A (es)	2011-11-18
TW201033200A (en)	2010-09-16
IL214543A0 (en)	2011-09-27
AR075399A1 (es)	2011-03-30
RU2011137435A (ru)	2013-03-20
TWI457335B (zh)	2014-10-21
FR2941947A1 (fr)	2010-08-13
WO2010092289A1 (fr)	2010-08-19
HK1164862A1 (en)	2012-09-28
AU2010212705A1 (en)	2011-09-22
US20120040996A1 (en)	2012-02-16
CN102361865B (zh)	2015-11-25
CN102361865A (zh)	2012-02-22
EP2396320B1 (fr)	2013-05-15

Similar Documents

Publication	Publication Date	Title
BRPI0907381A2 (pt)	2015-07-14	Derivados de carboxamidas azabicíclicos, o respectivo preparo e a respectiva aplicação em terapêutica.
BRPI1012857A2 (pt)	2019-09-24	derivados de ciclopenta[c]pirrol-2-carboxilatos, o respectivo preparo e a respectiva aplicação em terapêutica
DK2049525T3 (da)	2010-05-03	N-laminoheteroaryl)-1H-indol-2-carboxamid-derivater, og fremstilling og terapeutisk anvendelse deraf
IL204663A0 (en)	2010-11-30	Nicotinamide derivatives, preparastion thereof and therapeutic use thereof
ZA201100210B (en)	2012-03-28	Pyridino-pyridinone derivatives,preparation thereof,and therapeutic use thereof
BRPI0906567A2 (pt)	2015-07-07	Derivados de ureia de tetra-hidroquinoxalina, o respectivo preparo e a respectiva aplicação em terapêutica j
IL219530A0 (en)	2012-06-28	Substituted 4-aminocyclohexane derivatives and their use for preparing medicaments
BRPI0810440A2 (pt)	2014-10-14	Derivados de triazolopiridina-carboxamidas e triazolopirimidina-carboxamidas, o respectivo preparo e a respectiva aplicação em terapêutica
IL219888A0 (en)	2012-07-31	Pyridine-pyridinone derivatives, preparation and therapeutic use thereof
BRPI1008173A2 (pt)	2016-03-01	"derivados de piridina espiroindolinona"
BRPI0907578A2 (pt)	2019-09-24	derivados de 3-aminoalquil-1,3-di-hidro-2h-indol-2-ona, o respectivo preparo e a respectiva aplicação em terapêutica
ZA201203944B (en)	2013-08-28	(methylsulfonyl) ethyl benzene isoindoline derivatives and their therapeutical uses
BRPI0923875A2 (pt)	2015-07-21	Derivados de 2-piridin-2-il-pirazol-3 (2h)-ona, o respectivo preparo e a respectiva aplicação terapêutica.
ZA201107363B (en)	2012-12-27	Quinazolinedione derivatives,preparation thereof and various therapeutic uses thereof
ZA201200027B (en)	2013-03-27	Pyrazole derivatives, preparaton thereof, and therapeutic use thereof
IL202287A0 (en)	2010-06-16	Therapeutic pyrazolonaphthyridine derivatives
EP2344479A4 (en)	2012-05-30	1,2-BENZISOTHIAZOLINONE AND ISOINDOLINONE DERIVATIVES
DK2310383T3 (da)	2012-03-26	2-oxo-alkyl-1-piperazin-2-onderivater, fremstilling deraf og terapeutisk anvendelse deraf
BRPI0822054A2 (pt)	2015-06-23	Derivados de azetidinas, o respectivo preparo e a respectiva aplicação em terapêutica
BRPI1008501A2 (pt)	2019-09-24	derivados de 3-benzo furanil - indol-2-ona substituídos em posição 3, o respectivo preparo e a respectiva aplicação em terapêutica
SI2421864T1 (sl)	2014-11-28	1-pirazolo(4,3-c)izokinolinski derivati, njihova priprava in njihova terapevtska uporaba
BRPI0806969A2 (pt)	2014-04-08	Derivados de azabicicloalcano, o respectivo preparo e a respectiva aplicação em terapêutica
BRPI1010981A2 (pt)	2018-12-04	"derivados de fármaco redox"
BRPI0816239A2 (pt)	2015-02-24	Derivados terapêuticos de quinolina e naftaleno
IL214544A0 (en)	2011-09-27	Substituted 3-benzofuranyl-indol-2-one-3-acetamidopiperazine derivatives, preparation thereof, and therapeutic use thereof

Legal Events

Date	Code	Title	Description
2019-10-01	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
2020-01-21	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.